July 25, 2007 โ Using 64-slice coronary CT angiography as a diagnostic test poses a substantial risk of developing ...
July 25, 2007 โ According to a study published in the July 25 issue of JAMA, high-risk patients with hypertrophic ...
July 25, 2007 - St. Jude Medical, Inc. announced the first patient implant in its clinical trial of Trifecta, a new ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
July 25, 2007 - Teleflex Incorporated, a diversified company expanding medical technology business, and Arrow ...
July 25, 2007 - Researchers have confirmed that six new genetic variants increase the likelihood of developing coronary ...
July 24, 2007 - A new U.S. study published in the early online edition of Circulation, the journal of the American Heart ...
SPONSORED CONTENT โ Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
July 24, 2007 โ Biotonik announced that it has enrolled the first patient and largest trial, REPLACE Registry, which ...
July 22, 2007 โ ev3 Inc. and FoxHollow Technologies, Inc. announced a definitive agreement by which ev3 and FoxHollow ...
July 23, 2007 - Teleflex Inc., a global supplier of disposable medical products used in critical care, specialty medical, and surgical applications and Arrow International Inc. announced today that they have entered into a definitive agreement pursuant to which Teleflex will acquire Arrow in an all cash transaction valued at approximately $2 billion.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Source: Wall Street Journal Online July 20, 2007 - U.S. doctors implanted fewer coronary stents in June than any other ...
July 19, 2007 โ Abbott announced that the first patient was enrolled in its XIENCE V SPIRIT WOMEN clinical trial, the ...
July 20, 2007 โ Despite forecasts by analysts at Thomson Financial that Boston Scientific Corp. would earn $150 million ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 20, 2007 โ Oraganogenesis Inc. announced that it has received regulatory approval in Canada and Europe for BioSTAR, a device that incorporates a bioresorbable collagen scaffold used to treat patent foramen ovale (PFO), a hole in the heart that is usually asymptomatic.
July 19, 2007 โ AtCor Medical Holdings Ltd., the developer and marketer of the SphygmoCor system, which noninvasively ...
July 18, 2007 - An analysis based on computerized simulation models suggests that the lifetime risk of cancer associated ...
July 24, 2007
